Luis Garcia

Université De Versailles St Quentin
Montigny-sur-loing, 20261, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Antisense oligonucleotide selection scheme for rare Duchenne muscular dystrophy mutations: Application to DMD exon 16 skipping.

Antisense oligonucleotide selection scheme for rare Duchenne muscular dystrophy mutations: Application to DMD exon 16 skipping.

Journal: Molecular therapy. Nucleic acids

Published: February 05, 2026

Systemic distribution of tricyclo-DNA antisense oligonucleotide following intratracheal instillation in the mouse.

Systemic distribution of tricyclo-DNA antisense oligonucleotide following intratracheal instillation in the mouse.

Journal: NAR molecular medicine

Published: October 07, 2025

Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy.

Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy.

Journal: Molecular therapy. Nucleic acids

Published: August 22, 2025

Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy.

Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy.

Journal: Molecular therapy. Nucleic acids

Published: July 15, 2025

Combined 20-Hydroxyecdysone and Antisense-Mediated Exon Skipping Improve Functional Outcomes in a Mouse Model of Duchenne Muscular Dystrophy.

Combined 20-Hydroxyecdysone and Antisense-Mediated Exon Skipping Improve Functional Outcomes in a Mouse Model of Duchenne Muscular Dystrophy.

Journal: Nucleic acid therapeutics

Published: February 17, 2025

Valproic Acid Improves Antisense-Mediated Exon-Skipping Efficacy in mdx Mice.

Valproic Acid Improves Antisense-Mediated Exon-Skipping Efficacy in mdx Mice.

Journal: International journal of molecular sciences

Published: January 13, 2025

Impact of the Inhibition of Organic Anion Transporter on Tricyclo-DNA-Mediated Exon Skipping in the mdx Mouse Model.

Impact of the Inhibition of Organic Anion Transporter on Tricyclo-DNA-Mediated Exon Skipping in the mdx Mouse Model.

Journal: Nucleic acid therapeutics

Published: November 15, 2023

Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model.

Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model.

Journal: Biomedicines

Published: September 19, 2023

Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models.

Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models.

Journal: Cells

Published: February 12, 2023

Oligonucleotide Enhancing Compound Increases Tricyclo-DNA Mediated Exon-Skipping Efficacy in the Mdx Mouse Model.

Oligonucleotide Enhancing Compound Increases Tricyclo-DNA Mediated Exon-Skipping Efficacy in the Mdx Mouse Model.

Journal: Cells

Published: January 06, 2023

Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle.

Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 03, 2023

Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice.

Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice.

Journal: Molecular therapy. Nucleic acids

Published: October 20, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026